Search This Blog:    America  Racial  LGBT+




Feuding antibodies blocked HIV vaccine


Feuding antibodies blocked HIV vaccine

WASHINGTON — US researchers said Monday that a high-profile HIV vaccine trial that was shown to work in just under a third of patients may have been hindered by feuding antibodies. The vaccine trial, known as RV144, involved more than 16,000 HIV ...

Top stories of the last 30 days